Yet another alliance has been formed to help transform healthcare. This time 20 major employers, who represent 4 million employees and family members, have come together to improve how healthcare benefits are purchased.
Yet another alliance has been formed to help transform healthcare. This time 20 major employers, who represent 4 million employees and family members, have come together to improve how healthcare benefits are purchased.
The alliance will focus on reforms that can reduce redundancies and waste in the supply chain.
“The current system is unsustainable and it costs our employees too much,” Kevin Cox, the chief human resources officer of American Express, said in a statement. “Even the most successful companies won’t be able to afford the rising costs of health care in the not-too-distant future.”
The newly formed Health Transformation Alliance (HTA) will play a part of each participating company’s health strategy with the aim to increase innovation, better analyze data, and better leverage how corporations obtain coverage for workers.
In 2017, HTA will launch a pilot to help employees obtain more affordable prescription medications with other initiatives planned to begin in 2018 or later.
“Our priority in this coalition is supporting positive health outcomes for our strongest asset—our employees,” said Kim Hauer, the chief human resources officer at Caterpillar. “Health care benefits are too important to our people for us to sit on the sidelines; the status quo needs to change, and we have to be part of the solution. We are creating a better way of getting workers what they want and need.”
There are 4 main areas of focus of HTA:
“We have considerable work to do, and we expect this will take years to fully implement,” said Bill Allen, the CHRO of Macy’s Inc. “This is a major undertaking for each of us, but if we don’t do it now, the growth in health care costs will overwhelm all of us. We are proud to be pioneers who seek to transform and improve the way health care benefits are provided for millions of working Americans.”
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More